US Stock MarketDetailed Quotes

SPRO Spero Therapeutics

Watchlist
  • 1.222
  • +0.042+3.57%
Trading Nov 4 11:31 ET
66.05MMarket Cap3.59P/E (TTM)

About Spero Therapeutics Company

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.

Company Profile

SymbolSPRO
Company NameSpero Therapeutics
Listing DateNov 2, 2017
Issue Price14.00
Founded2013
CEOMr. Satyavrat Shukla, C.F.A.
MarketNASDAQ
Employees46
Fiscal Year Ends12-31
Address675 Massachusetts Avenue,14th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-857-242-1600
Websitehttp://www.sperotherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Satyavrat Shukla, C.F.A.
  • Director, President and Chief Executive Officer
  • 2.02M
  • Esther Rajavelu
  • Principal Accounting Officer, Chief Financial Officer, Treasurer and Chief Business Officer
  • --
  • Dr. Kamal Hamed, M.D.
  • Chief Medical Officer
  • --
  • Timothy Keutzer
  • Chief Operating Officer
  • 1.44M
  • Dr. Ankit Mahadevia, M.D.
  • Chairman of the Board
  • 2.39M
  • Kathleen Tregoning
  • Independent Director
  • 73.17K
  • Scott T. Jackson, M.B.A.
  • Independent Director
  • 80.70K
  • Frank E. Thomas
  • Independent Director
  • 88.83K
  • Dr. Patrick V.J.J. Vink, M.D.
  • Lead Independent Director
  • 93.19K
  • Dr. Milind S. Deshpande, PhD
  • Independent Director
  • 105.70K
  • Cynthia Smith
  • Independent Director
  • 73.20K
  • Dr. John C. Pottage,Jr,M.D.
  • Independent Director
  • 83.20K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data